Fertility Preservation Insurance Coverage in Professional Schools

Gupta, Sonali; Amir, Jawaria; Petersen, A. K.; Prabhu, Sarala; Haider, Sadia; York, Sloane L.

doi:10.1016/j.fertnstert.2022.08.135

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The issue of cost is compounded by the usual lack of insurance coverage for fertility services. Even for patients with health insurance, fertility preservation services frequently are not covered [56]. Some US states mandate coverage for fertility preservation, but even among these states the services covered and rates of coverage vary widely, and the mandate may not apply to all insurers [56,57].…”

Section: Financial Barriersmentioning

confidence: 99%

“…Even for patients with health insurance, fertility preservation services frequently are not covered [56]. Some US states mandate coverage for fertility preservation, but even among these states the services covered and rates of coverage vary widely, and the mandate may not apply to all insurers [56,57]. Additionally, transgender patients are more likely than other patients to lack insurance coverage [58] and to earn income at a level below the poverty line [24] creating further barriers to care.…”

Section: Financial Barriersmentioning

confidence: 99%

See 1 more Smart Citation

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Dana,

Assaly

et al. 2023

Preprint

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, ovarian tissue, or embryos. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hindered the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.; fertility; transgender; reproductive technology.

show abstract

Section: Financial Barriersmentioning

confidence: 99%